New study maps developmental milestones in babies with rare genetic conditions
NCT ID NCT03967743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 43 infants with rare genetic disorders to track their development from birth up to age 3, with medical records reviewed until age 18. Researchers used a standard developmental assessment tool to understand each child's unique needs. The goal was to gather information, not to test a treatment, so there was no direct benefit to participants. Findings may help doctors better support these children in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENT, CHILD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common drug shield the brain from Alzheimer's?
- Money talks: Clinic-Based financial coaching may improve health and child development
- Talking therapy for NICU parents may boost premature babies' futures
- Training young taste buds: study tests if Low-Sugar snacks can curb Kids' sweet tooth
- Massive global registry aims to unlock secrets of rett syndrome
- Biobank aims to unlock genetic secrets of rare diseases